Interleukin 5 (1175) has been suggested to be involved in the growth and differentiation of B cells and eosinophils. Especially, Ly-1+ B cells, which have been considered to produce autoantibodies, are selectively developed by this lymphokine in long-term bone marrow culture . To envisage the possible engagement of IL5 in the development of these cells in vivo, transgenic mice carrying the mouse IL5 gene ligated with a metallothionein promoter were generated . Transgenic mice carrying the 1175 gene exhibited elevated levels of 11,5 in the serum and an increase in the levels of serum IgM and IgA. A massive eosinophilia in peripheral blood, bone marrow, and spleen, and an infiltration ofmuscle and liver with eosinophils, were observed. When cadmiumcontaining saline was injected intraperitoneally into transgenic mice, IM production was augmented about five times within 24 h, and a distinctive Ly-1 + B cell population became apparent in the spleen after 5 d. 1175 receptors were detected on those cells by monoclonal antibodies against IL-5 receptors. Another interesting finding in these transgenic mice was an increase in polyreactive anti-DNA antibodies of IgM class. It is suggested, therefore, that aberrant expression of the IL5 gene may induce accumulation of Ly-1+ B cells and eosinophils. Furthermore, this IL5 transgenic mouse can be a model mouse for eosinophilia, and we can determine the role of IL5 in the differentiation of Ly-1 + B cells and eosinophils by using this mouse.
Summary
Interleukin 5 (1175) has been suggested to be involved in the growth and differentiation of B cells and eosinophils. Especially, Ly-1+ B cells, which have been considered to produce autoantibodies, are selectively developed by this lymphokine in long-term bone marrow culture . To envisage the possible engagement of IL5 in the development of these cells in vivo, transgenic mice carrying the mouse IL5 gene ligated with a metallothionein promoter were generated . Transgenic mice carrying the 1175 gene exhibited elevated levels of 11,5 in the serum and an increase in the levels of serum IgM and IgA. A massive eosinophilia in peripheral blood, bone marrow, and spleen, and an infiltration ofmuscle and liver with eosinophils, were observed. When cadmiumcontaining saline was injected intraperitoneally into transgenic mice, IM production was augmented about five times within 24 h, and a distinctive Ly-1 + B cell population became apparent in the spleen after 5 d. 1175 receptors were detected on those cells by monoclonal antibodies against IL-5 receptors. Another interesting finding in these transgenic mice was an increase in polyreactive anti-DNA antibodies of IgM class. It is suggested, therefore, that aberrant expression of the IL5 gene may induce accumulation of Ly-1+ B cells and eosinophils. Furthermore, this IL5 transgenic mouse can be a model mouse for eosinophilia, and we can determine the role of IL5 in the differentiation of Ly-1 + B cells and eosinophils by using this mouse. T he study of IL5'originated in the search for one of the B cell growth and differentiation factors, named T cell-replacing factor (TRF), 1 that induces antigen-stimulated B cells to differentiate into plasma cells (1) (2) (3) or growth of BCLi B cell tumor (BCGFII) (4) . On the other hand, eosinophil differentiation factor (5) has been known as a diffusible factor from thoracic duct lymphocytes ofparasite-infected rats (6) . The cDNA cloning (7) (8) (9) and the mAb against IIr5 (10) enabled us to identify this molecule as a cytokine that has been known to induce activated B cells into IgM-and IgA secreting cells (7) (8) (9) (10) (11) (12) , to maintain the growth ofB cells (13) (14) (15) , to induce the expression of the IL2R a chain on the surface of B and T lymphocytes (16) (17) (18) , to stimulate growth and differentiation ofeosinophils (5, 9, 19, 20) , and to play a major ' Abbreviations used in this paper. mmTi, mouse metallothionein promoter; PE-Av, phycoerythrin-conjugated streptoavidin ; TNP, 2,4,6-trinitrophenyl hapten; TRF, T cell-replacing factor. role in T cell-dependent antibody production (21, 22) . 11,5 is an inducible hormone (23) produced mainly by T cells after antigen stimulation such as Mycobacterium tuberculosis or Toxocara canis (24, 25) .
We also observed in an in vitro bone marrow culture that 11,5 could work as growth and differentiation factor for eosinophils and that Ly-1+ B lineage cells were selectively maintained in the presence of 11,5 (26) . Ly-1 + B cells are a minor population of B lineage cells that are known to produce a restricted immunoglobulin repertoire including autoantibodies (27, 28) . It is not clear, however, whether Ly-1 + B cells are involved in the production of autoantibodies in vivo. It is important, therefore, to evaluate whether or not autoantibodies are produced according to the increased incidence of Ly-1+ B cells by continuous exposure of hematopoietic stem cells to IM. We describe here the production of transgenic mice by introducing the mouse IIr5 cDNA ligated to mouse metallothionein promoter (mMTI). A mas-sive eosinophilia and an expansion of Ly-1+ B cells in the spleen were observed in the resulting transgenic mice. The production of polyreactive IgM antibody against singlestranded (ss) and double-stranded (ds) DNA was seen in 11,5 transgenic mice.
Materials and Methods
Construction of the mMTI--IL5 Gene and Production of Transgenic Mice. EcoRI-Bg1II mMTI promoter fragment from pdBPVmMT neo vector (a generous gift from Dr. P. Howley, NIH, Bethesda, MD) (29) was used to express murine IL5 (mIIr5) cDNA. The 3' untranslated region of mIL5 cDNA that contains an AU-rich sequence was removed. The structure of the mMTI-IL5 gene is shown in Fig. 1 . The Xmnl-Nrul fragment of this construct was microinjected into the pronuclei of fertilized eggs of C3H/HeN mice as described (30) . For screening of transgenic mice, mouse tail DNA was isolated according to the procedures described previously (31) and digested with BamHI. Digested DNA was analyzed as described by Southern (32) . The 11,5 probe used was the 461-bp Sacl-Accl fragment of pSP6K-nTRF23 (24) .
Assessment of 11,5 Activity by BCGFII Assay. 11,5 activities of rIL5 were assessed by DNA synthesis with the use of T88-M cells (BCGFII assay) (23, 26) , and were expressed in nanograms per milliliter. IL5-dependent T88-M cells were inoculated in a 96-well microtiter plate at a concentration of 1.5 x 104/0 .2 ml/well with serially diluted samples to be tested . Uptake of ['H]thymidine by these cells, which had been pulsed with 0.2 P,Ci/well during the last 6 h of a 48-h culture, was determined in a liquid scintillation counter. DNA synthesis was determined by means of [3H]thymidine incorporation. In each assay, affinity-purified rIL5 was also included as a standard (23) .
ELISA to Detect IL5. Anti-IL5 mAb NC17 (100 ttg/ml) was coated onto polyvinyl plate wells (Micro Test III; 3911; Becton Dickinson & Co ., Oxnard, CA), and the nonspecific binding sites were blocked with PBS (10 mM phosphate, 140 mM NaCl, pH 7.2) containing 2% BSA. Samples were then applied to the wells and incubated overnight at room temperature . After washing the wells with PBS containing 0.05% Tween 20, polyclonal rabbit anti-murine IL-5 antibodies were added to the wells, followed by a 4-h incubation at room temperature. Then, horseradish peroxidase-coupled goat anti-rabbit Ig (Bio-Rad Laboratories, Richmond, CA) and 2,2'-azino-di (3-ethyl)benzthiazoline sulfonic acid (ABTS) were used as a coloring system according to the manufacturer's recommendation. OD was read at 405 nm . Standard curve was obtained by using purified rIL5 .
Northern Blot Analysis. Total RNAs were isolated by the guanidine isothiocyanate method (33) . 20 Wg of total RNA from each sample was analyzed by Northern blotting as described (34) . "P-labeled SacI-Accl fragment of 11,5 cDNA (prepared by using Oligolabeling kit from Pharmacia Fine Chemicals, Piscataway, NJ) was used as a probe. Results were shown through Bio Analyzer 100 (Fuji Photo Film, Tokyo, Japan) .
Fluorescence-activated Cell Sorter (FRCS®) Analysis. Total spleen cells, peritoneal exudate cells, and bone marrow cells from transgenic mice and age-matched control mice were prepared after removing red blood cells. They (106) were stained with biotinylated rat mAb against CD5 (Ly- Serum immunoglobulin levels were assessed by ELISA by using isotype-specific antibodies as described (12) . Results were expressed as micrograms per milliliter serum. Anti-ssDNA and anti-dsDNA antibodies were also measured by ELISA as described previously (40) with a slight modification . Briefly, ssDNA or dsDNA purified from calf thymus DNA, according to the method of Stollar and Papalian (41) was coated on 96-well assayplates (3921; Becton Dickinson & Co .) that had been precoated with poly-L-lysine. These plates were blocked with TBS (25 mM Tris, 140 mM NaCl, pH 7.4) containing 5% FCS and 0.05% Tween 20 . Sera were diluted 1:100 with TBS containing 5% FCS. After each incubation, the plates were washed with TBS containing 0.05% Tween 20 . Bound antibodies were detected with alkaline phosphatase-conjugated rabbit anti-mouse IgG (Pel-Freez Biologicals, Rogers, AZ) or with alkaline phosphatase-conjugated rabbit anti-mouse IgM (Zymed, South San Francisco, CA). The substrate was p-nitrophenylphosphate (Sigma Chemical Co ., St . Louis, MO). Antibody activity was expressed as the absorbance at 405 nm in a Titerteck Multiscan ELISA reader (Flow Technologies, Inc., Phoenix, AZ). Anticardiolipin and antitrinitrophenyl hapten (TNP) antibodies were similarly measured by ELISA with minor modifications as described previously (42, 43) . Histology. Organs were fixed in phosphate buffered 10% formalin (35 mM phosphate, pH 7.0) and embedded in paraffin . Sections were stained with hematoxylin and eosin.
Results
Transgene Construct . Because mMTI promoter is known to be expressed and inducible in various organs such as liver, kidney, intestine, heart, testis, muscle, brain, and spleen, we used this promoter for expressing IL-5 ( Fig . 1 ) . Murine 1175 cDNA that has no 3' untranslated region was inserted into a part of rabbit (3-globin gene derived from pKCR vector (44) and ligated to the mMTI promoter.
Production of 1L5 Transgenic Mice. Two male mice (Nos . 3 and 6) were transgenic and were shown to carry about 5 or 40 copies of transgene by Southern blot analysis, respectively (Fig. 2 a) . Both founders transmitted transgenes to half of their offspring without regard to their sex. Although half of the offspring of mouse No . 3 integrated 11,5 transgene, 11,5 expression in terms of eosinophilia in peripheral blood (see below) was very poor and variable among mice (-10% eosinophils in hemizygote and <15% in homozygote even in aged mice). We therefore mainly analyzed IL5 transgenic mice derived from No . 6 mouse in this study.
The discrimination between hemizygotes and homozygotes was possible by measuring the relative density of the 23-kb band (endogenous IL5 gene) to the 5-kb band (transgene) in the Southern blot described above (Fig. 2 b) . It was also confirmed by the serum IgM level ( determine mRNA expression in IL5 transgenic mice, Northern blot analysis was performed using total RNA of liver and spleen cells from cadmium-treated normal or IL-5 transgenic mice. Although both endogenous and transgene-derived mRNA were of mouse origin, they were different in their size. 11,5 mRNA from normal 116-producing hybridoma B151K12 is 1 .7 kb, as described (24), and the transgenic IL5 mRNA is 1 .1 kb, as expected from L cells transfected with pKCR-mMT I-mIL5 (the same construct used to make transgenic mice) . The latter was probably caused by the removal of the 3' untranslated region of IL-5 cDNA and the artificial polyadenylation sites . Transcripts with the expected length (1.1 kb) hybridizable with mouse IL-5 cDNA was detected in RNA prepared from liver and spleen cells of the cadmiumtreated IL5 transgenic mice (Fig. 3) . Although the 1.1-kb IL-5 mRNA band was also detected in the RNA from spleen and liver of IL-5 transgenic mice without cadmium administration, its expression was low (data not shown) . We could not detect either size of IL-5 mRNA in the RNA prepared from spleen and liver cells of cadmium-treated nontransgenic mice under the conditions used in this study. IL-5 transgene expression in liver was very variable, while that in spleen was very constant among four mice of fourth generation. The serum IL-5 level was determined by both biological assay using the 11r5-dependent T88-M cells and ELISA as described in Materials and Methods . Since we observed similar results in both assay systems, we only described the data by ELISA . The average serum IL-5 level in hemizygotes at 7 wk was 0 .11 nit/ml, and that in homozygotes was 2 .8 and 16 .6 nit/ml at 7 and 25 wk of age, respectively (Table 1) . However, we could not found any IL5 activity in age-matched control mice or in littermate mice (<0 .01 nit/ml) . Thus, serum IL-5 levels in these homozygous IL-5 transgenic mice were estimated to be at least 1,600-fold higher than normal level in 25-wk-old mice . By injecting cadmium sulfate solution into IL-5 transgenic mice, IL5 levels in their sera were increased about fivefold within 24 h. These data clearly indicated that the mouse IL5 transgene, which was inducible upon stimulation with cadmium, was expressed constitutively at least in liver and spleen . IL-5 transgene expression was also observed in bone marrow and kidney (data not shown) . Serum immunoglobulin levels in these transgenic mice were examined by ELISA. As shown in Table 1 , the levels of serum IgM and IgA were approximately eightfold and fourfold higher as compared with those of age-matched control mice that were 7-wk-old, respectively. IgG1 and IgG2a were found to be within control level. In 25-wk-old mice, IgM and IgA levels in the sera of transgenic mice were -5-and 1.4-fold higher than those of age-matched control mice, respectively. Immunoglobulin levels of the sera of these transgenic mice were not increased by the cadmium treatment.
The most striking feature of transgenic mice was a marked increase in the number of peripheral white blood cells (PBL), of spleen cells, and of peritoneal cells. The total numbers of PBL of hemizygous and homozygous transgenic mice were -2 .0 and -3 .4 times higher than those in littermate control mice, respectively (Table 2) . Particularly, the increase in the number of eosinophils was at least 20-fold (hemizygote) to 70-fold (homozygote) compared with that of age-matched control normal mice. Although the number of total lym- phocytes and neutrophils were slightly increased in transgenic mice, the numbers of monocytes were found to remain within normal range. Peritoneal cavity of the littermate control mice contained 2-6 x 106 cells. In contrast, there were as many as 2 . in its number by the administration of cadmium into the 25-wk-old mice (Fig. 4, a vs. b) . Furthermore, this population has higher density of IgM on its cell surface (Fig . 4,  c vs. d) . This Ly-1+ population also expresses IL-5R (H7 antigen) (Fig. 4f) . These results suggest that in IL5 transgenic mice, ILSRpositive cells are selectively expanded and some of them also coexpress Ly-1 antigens simultaneously.
No difference in the ratio of CD4+ over CD8+ or of CZ/0+ over , y /S+ was observed among T lymphocytes, and we could not find any increase in allo-killer or MLR activity in IL5 transgenic mice (data not shown) .
Autoantibody Production in 11,5 Transgenic Mice The increase in the total number of Ly-1+ and IL5R+ B cells in the peritoneal cavity and the spleen in IL5 transgenic mice prompted us to examine the production of autoantibodies in the transgenic mice, because Ly-1+ B cells are supposed to produce autoantibodies (45) (46) (47) . To examine the levels of autoantibodies, we adopted ssDNA, dsDNA, and cardiolipin as test antigens . As a control antigen, TNP was also used . As shown in Fig . 5 , we could detect IgM autoantibodies against each antigen in the sera of all 11,5 transgenic mice (six mice are hemizygotes and four mice were homozygote), although the titer in each mouse was variable. These sera reacted also to TNP, and antibody activity to each antigen was absorbed by ssDNA or dsDNAcoupled Sepharose beads (data not shown), indicating that autoantibodies are polyreactive. No anti-DNA antibodies were found in IgA or IgG fraction (data not shown) .
Pathological Findings in Tissues of11,5 Transgenic Mice. To examine the pathological changes in the IL5 transgenic mice, two homozygous transgenic mice were killed at 20-25 wk of age. The other two homozygous transgenic mice, which had received four consecutive intraperitoneal injections of cadmium on days 19, 14, 10, and 5 before death, were also subjected to pathological examination . After cadmium treatment, the spleen was enlarged (about five times in cell number) and had white patches consisting of the mass of eosinophils. All the specimens shown in Fig. 6 are from cadmium-injected mice. Both of them showed splenomegaly, and no detectable lymph node enlargement . In the spleen, eosinophils were seen in the marginal area and some of them form colony-like proliferations (indicated by an arrow) all over the spleens (Fig.  6 a) . Erythroblasts and megakaryocytes were seen more frequently than in normal spleen . Eosinophils were rarely seen in normal spleen cells . Large parts of bone marrow were occupied by mature or immature eosinophils. In the liver, infiltration of eosinophils was mainly observed in Glisson's capsule, and slightly in lobes. Eosinophil infiltration was also seen in the muscle, and derangement of sarcolemma and disappearance of striation were observed . Moreover, we also observed mass of eosinophils along connective or fat tissue sorrounding muscle. In both cases there was infiltration of eosinophils with ring-or U-shaped nuclei and cytoplasm full of red granules. The typical eosinophils seen in peripheral blood of IL5 transgenic mice were shown in Fig. 6 b. The nuclei of eosinophils were found most frequently as a ringshaped structure, which sometimes showed a folded "figure- 43 4 Interleukin 5 Transgenic Mice eight" structure . The ring form was always an even-sized band (Fig. 6 b) . Although the mouse neutrophils also had ringshaped nuclei, they were frequently lobulated . The cytoplasm of eosinophils was filled with small, acidophilic granules which were even in their size. In contrast, the granules of mouse neutrophils were stained poorly and mouse neutrophils appeared to lack cytoplasmic granules.
Discussion
In this study, we describe the generation of a massive eosinophilia and production of polyreactive autoantibodies in IL-5 transgenic mice in which mouse IL5 cDNA is constitutively expressed. This eosinophilia is characterized as follows : (a) the presence of eosinophils with mitosis in spleen, bone marrow, and liver ; (b) infiltration of many organs with eosinophils, including liver, muscle, heart, lymph node along the bronchus, and Peyer's patches ; eosinophils have a tendency to lodge around the connective tissue such as marginal area of spleen, liver, Peyer's patches, and between muscle and fat tissue . Eosinophils probably have some affinity to the certain matrix in connective tissue . In case of muscle, it might be a sign of myositis or fascitis. This feature reminds us of Shulman's disease (48); (c) the presence of massive eosinophils in peripheral blood. All these data suggest that IL5 transgenic mouse can be a model of idiopathic hypereosinophilic syndrome (49) . Especially, hypereosinophilic syndrome induced by a graft-vs .-host reaction appears to be caused by 1175, because IL5 is known to be produced in a large amount by alloreactive T cells (49, 7) .
It is reasonable to expect that in IL5 transgenic mice, the total number of IL5R-positive B cells are increased . We also asked if Ly-1 + B cells are increased or not in these transgenic mice, because we observed high incidence of Ly-1+ early B cells in the long-term bone marrow culture on the stromal cells in the presence of IL5 (26, 50) . We used mAb H7 (38, 39) against IL5R to analyze numbers and distribution of 11,5R-positive cells. In normal mice, most peritoneal surface IgM+ B cells were IL5R positive, and >70% of 11,5R-positive B cells express Ly-1 antigens on their cell surface (39) . On the contrary, only small populations of splenic B cells are H71°» positive, and the H7duu and Ly-1 double-positive cells are marginal (39) .
Ly-1 + B cells are a distinct minor subpopulation of B cells and have numerous noteworthy characteristics (for reviews see references 27, 28, 51, 52), such as self-replenishing activity (53-55), particular tissue distribution (abundant in the peritoneal cavity) (46, 53) , and production of autoantibodies (45) (46) (47) . Furthermore, functional studies have suggested that Ly-1+ B cells are selected for the expression of a restricted repertoire of antibody specificities (52, 56) . These are the major reasons why Ly-1+ B cells have been considered to be of a separate B cell lineage.
In IL5 transgenic mice, Ly-1+ B cell population is not relatively increased in peritoneal lymhocytes. In the spleen, however, B220 and Ly-lduu-positive B cells were dramatically increased and many of them were surface IgM and H7 positive.
Ly-1 density on their cell surface seems to be lower than those on peritoneal cells of normal littermate . This distinctive Ly-1+ and B220+ population was also seen in the bone marrow cells, though it was not as clear as in the spleen . This less extensive domination of weakly Ly-1+ and B220+ populations in the bone marrow may partly be explained by the occupation of medullary cavity by eosinophils. This increase in the number of Ly-1+ B cells and eosinophils could be waned by intraperitoneal injection of anti-IL-5 antibody (data not shown) .
Mechanism of the preferential increase of Ly-1 + B cell population in the spleen of IL-5 transgenic mice is not fully understood, but direct involvement of 11,5 is highly possible. In vitro growth of Ly-1 + pre-B cells and chronic B cell leukemia cells were shown to depend on 11,5 (4, 7, 14) . Recently, we established early B lineage cell lines dependent on stromal cell line ST2 and IIr5 by using Whitlock-Witte type bone marrow culture system . Surprisingly, all 18 clones we established were Ly-1+, while early B lineage cells established in the absence of 11,5 at the same time are rarely Ly-1 + (26, 50) . We also presented evidence that bone marrow cells from 3-wk-old mice contains Ly-1 + B cell precursors and these cells could be selectively maintained in the presence of IL-5 and bone marrow-derived stromal cells (50) . By culturing bone marrow cells either from 8-or 3-wk-old 1175 transgenic mice, we found the generation of IL5-responsive Ly-1+ cells even in the absence of 116, suggesting that Ly-1 + B cells may well be maintained in bone marrow of adult IL-5 transgenic mice. However, we could not observe the fully mature Ly-1 + B cells in this in vitro culture system, although they become pre-B cells expressing 2 .7-kb membrane type it mRNA (50). This I1,5 transgenic mouse confirmed the involvement ofIL-5 in the development of Ly1+ B cells in vivo.
The findings described in this study indicate the essential role of deregulated production of IL-5 in eosinophilia and preferential growth of Ly-1 + B cells that resulted in the increase in total numbers of Ly-1 + B cells in the spleen . IL5 is probably involved in the production of polyreactive IgM antibodies in IIr5 transgenic mice, because similar polyreactive IgM autoantibodies containing anti-DNA activity could be elicited by the intraperitoneal injection of 1 hg pure IL-5 (data not shown) . However, we do not have direct evidence indicating polyreactive anti-DNA antibodies are produced by Ly-1 + B cells. It is very unlikely that polyreactive anti-DNA antibodies are produced only by Ly-1 + B cells, because there are significant amounts B cells that do not express Ly-1 antigen but express IL-5 receptors .
The fact that those polyreactive anti-DNA antibodies can be recovered from a DNA Sepharose column with 0.5 M NaCl at neutral pH suggests that the antigenic determinant recognized by these autoantibodies is the conformational structure (43) . This trait of anti-DNA antibodies is shared with the naturally occurring anti-DNA antibodies in patients with SLE or in lupus model mice (43) .
The relation of these polyreactive autoantibodies to autoimmunity is unknown . It is suggested that the class switch of these autoantibodies from IgM to IgG may cause lupus (57) . We introduced our IL5 transgene into mice having genetic backgrounds that facilitate the progression of autoimmunity, such as MRL/lpr or NZW by mating, but so far, no such class switch was observed . Continuous expression of IL-5 might be rather inhibitory for the outbreak of the disease. It might be expressed transiently before the onset of lupus . We are currently trying to induce IL5 transgenic mice to make a class switch from IgM to IgG.
In general, these polyreactive autoantibodies are known as naturally occurring antibodies in normal serum and are believed to be engaged in the primary protection against infection of microorganisms (27, 28, 53, 58) . On the other hand, eosinophils are also believed to be involved in the protection against parasites, and 11,5 is known to be induced when mice are infected with parasites (25, 59) . Taken together, IL-5 seems to engage in the primary defense mechanism against the infection of parasites and microorganisms. We are currently investigating if these mice are really resistant against the infection of microorganisms.
